Locoregional therapies are commonly used to treat patients with hepatocellular carcinoma. It
has been noted for many years that locoregional therapies may have additional systemic …

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide.
Local ablation, such as radiofrequency ablation, microwave ablation, cryoablation and …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortalities
worldwide. Patients with early-stage HCC are eligible for curative treatments, such as …

Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Unlike other types of cancer, HCC can be treated with locoregional treatments (LRTs) such …

Hepatocellular carcinoma (HCC) is associated with a highly heterogeneous immune
environment that produces an immune response to various locoregional treatments (LRTs) …

Microwave (MW) thermal therapy has been developed as an effective clinical strategy that
can achieve pronounced antitumor activity and also has the potential to trigger antitumor …

Background Glycosylation plays an essential role in driving the progression and treatment
resistance of hepatocellular carcinoma (HCC). However, its function in regulating the …

Recent advancement in the immunological understanding of genesis of hepatocellular
carcinoma (HCC) has implicated a decline in anti-tumour immunity on the background of …

Hepatocellular carcinoma (HCC) is the most common type of primary liver malignancy and
the fourth leading cause of cancer-related deaths globally. HCC is often diagnosed in late …

Background In recent years, papillary thyroid microcarcinoma (PTMC) has been a main
cause of the high incidence of thyroid carcinoma. No existing study has reported whether …